Skip to main content

Dicarbonyl-mediated protein modifications affect matrix metalloproteinase (MMP) activity

Proteinmodifizierungen durch Dicarbonyle beeinträchtigen die Matrixmetalloproteinase (MMP)-Aktivität

Abstract

Advanced age is linked with an increased incidence of epithelial tumours (carcinomas) including lung tumours. However, a slowing rate of the increase of age-specific cancer incidence is demonstrated at very advanced ages, and elderly patients also develop less invasive and metastatic tumours than their younger counterparts. Matrix metalloproteinases (MMPs) are commonly upregulated in the stromal compartment of the carcinoma tissue and are believed to promote invasion and metastasis. As the increased serum and tissue level of advanced glycation end products (AGEs) is a characteristic feature of old humans, our study focused on the impact of AGEs on the activity of MMPs released from lung fibroblasts (WI- 38). The collagen gel zymography technique showed the primary presence of MMP-2 in the conditioned medium of the WI-38 fibroblasts, which was even higher in senescent WI-38 fibroblasts. Subsequent treatment of the WI- 38 conditioned medium with the dicarbonyl compound glyoxal, a highly reactive precursor of the AGE formation, resulted in a dose-dependent reduction of the MMP-2 activity. Therefore, our study suggests that the age-associated increase in AGEs might be one potential host factor responsible for the less invasiveness of tumours at very advanced age.

Zusammenfassung

Mit zunehmendem Alter nimmt auch die Häufigkeit von Tumorerkrankungen zu, wobei die epithelialen Tumore (Karzinome) eine besondere Stellung einnehmen. Die Anzahl der Krebserkrankung stagniert jedoch im sehr hohen Lebensalter. Darüber hinaus sind auch die Aggressivität und die Entstehung von Metastasen bei sehr alten Patienten vermindert. Beim invasiven Wachstum und der Metastasierung des Tumors spielen Matrixmetalloproteinasen (MMPs) eine bedeutende Rolle, die im Stromabereich vieler Tumorgewebe erhöht sind. Da es mit dem zunehmenden Lebensalter auch zum Anstieg von Glykierungsendprodukten, den so genannten AGEs, im Serum und in den Organen kommt, haben wir in unserer Studie den Einfluss der AGEBildung auf die Aktivität der MMPs untersucht. Mit Hilfe der Zymographietechnik konnte ein hoher Gehalt an extrazellulärem MMP-2 in den Zellkulturüberständen von Lungenfibroblasten (WI-38) bestimmt werden. Die MMP-2-Sekretion durch seneszente WI-38-Fibroblasten war zudem höher als die durch prä-seneszente WI-38. Die Behandlung der WI-38-Zellkulturüberstände mit der Dicarbonylverbindung Glyoxal, einem reaktiven Vorläufer der AGE-Bildung, führte zu einer dosisabhängigen Reduktion der MMP-2-Aktivität. Aus diesen Daten können wir schlussfolgern, dass die altersassoziierte Erhöhung von AGEs im Körper ein potentieller Faktor ist, der zur verminderten Aggressivität des Tumorwachstums im sehr hohen Lebensalter beiträgt.

This is a preview of subscription content, access via your institution.

References

  1. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562–573

    PubMed  Article  CAS  Google Scholar 

  2. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491–21494

    PubMed  Article  CAS  Google Scholar 

  3. Hofmann HS, Hansen G, Richter G, Taege C, Simm A, Silber RE, Burdach S (2005) Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res 11:1086–1092

    PubMed  CAS  Google Scholar 

  4. Piantanelli L (1988) Cancer and aging: from the kinetics of biological parameters to the kinetics of cancer incidence and mortality. Ann NY Acad Sci 521:99–109

    PubMed  Article  CAS  Google Scholar 

  5. Ershler WB, Socinski MA, Greene CJ (1983) Bronchogenic cancer, metastases, and aging. J Am Geriatr Soc 31:673–676

    PubMed  CAS  Google Scholar 

  6. Ershler WB, Stewart JA, Hacker MP, Moore AL, Tindle BH (1984) B16 murine melanoma and aging: slower growth and longer survival in old mice. J Natl Cancer Inst 72:161–164

    PubMed  CAS  Google Scholar 

  7. Dyer DG, Blackledge JA, Katz BM, Hull CJ, Adkisson HD, Thorpe SR, Lyons TJ, Baynes JW (1991) The Maillard reaction in vivo. Z Ernährungswiss 30:29–45

    PubMed  Article  CAS  Google Scholar 

  8. Uribarri J, Cai W, Peppa M, Goodman S, Ferrucci L, Striker G, Vlassara H (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 62:427–433

    PubMed  Google Scholar 

  9. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363–9367

    PubMed  Article  CAS  Google Scholar 

  10. Bartling B, Fuchs C, Somoza V, Niemann B, Silber RE, Simm A (2007) Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo. Mol Nutr Food Res 51:479–487

    PubMed  Article  CAS  Google Scholar 

  11. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839

    PubMed  Article  CAS  Google Scholar 

  12. Parrinello S, Coppe JP, Krtolica A, Campisi J (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J Cell Sci 118:485–496

    PubMed  Article  CAS  Google Scholar 

  13. Thornalley PJ, Langborg A, Minhas H (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344:109–116

    PubMed  Article  CAS  Google Scholar 

  14. Ahmed MU, Thorpe SR, Baynes JW (1986) Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889–4894

    PubMed  CAS  Google Scholar 

  15. Iijima K, Murata M, Takahara H, Irie S, Fujimoto D (2000) Identification of N(omega)-carboxymethylarginine as a novel acid-labile advanced glycation end product in collagen. Biochem J 347 Pt 1:23–27

    PubMed  Article  CAS  Google Scholar 

  16. Munch G, Schicktanz D, Behme A, Gerlach M, Riederer P, Palm D, Schinzel R (1999) Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library. Nat Biotechnol 17:1006–1010

    PubMed  Article  CAS  Google Scholar 

  17. Kang JH (2003) Modification and inactivation of human Cu,Zn-superoxide dismutase by methylglyoxal. Mol Cells 15:194–199

    PubMed  CAS  Google Scholar 

  18. Bode W, Gomis-Ruth FX, Stockler W (1993) Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Metturn) and topologies and should be grouped into a common family, the ‘metzincins’. FEBS Lett 331:134–140

    PubMed  Article  CAS  Google Scholar 

  19. Morgan PE, Dean RT, Davies MJ (2002) Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch Biochem Biophys 403:259–269

    PubMed  Article  CAS  Google Scholar 

  20. Knott HM, Brown BE, Davies MJ, Dean RT (2003) Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Eur J Biochem 270:3572–3582

    PubMed  Article  CAS  Google Scholar 

  21. Ulrich P, Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56:1–21

    PubMed  Article  CAS  Google Scholar 

  22. Stitt AW, Jenkins AJ, Cooper ME (2002) Advanced glycation end products and diabetic complications. Expert Opin Investig Drugs 11:1205–1223

    PubMed  Article  Google Scholar 

  23. Henle T, Miyata T (2003) Advanced glycation end products in uremia. Adv Ren Replace Ther 10:321–331

    PubMed  Article  Google Scholar 

  24. Niwa H, Takeda A, Wakai M, Miyata T, Yasuda Y, Mitsuma T, Kurokawa K, Sobue G (1998) Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. Biochem Biophys Res Commun 248:93–97

    PubMed  Article  CAS  Google Scholar 

  25. Bellmunt MJ, Portero M, Pamplona R, Muntaner M, Prat J (1995) Age-related fluorescence in rat lung collagen. Lung 173:177–185

    PubMed  Article  CAS  Google Scholar 

  26. Bjorklund M, Koivunen E (2005) Gelatinase- mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755:37–69

    PubMed  Google Scholar 

  27. Ashcroft GS, Mills SJ, Ashworth JJ (2002) Ageing and wound healing. Biogerontology 3:337–345

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to B. Bartling.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bartling, B., Desole, M., Silber, RE. et al. Dicarbonyl-mediated protein modifications affect matrix metalloproteinase (MMP) activity. Z Gerontol Geriat 40, 357–361 (2007). https://doi.org/10.1007/s00391-007-0485-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00391-007-0485-8

Key words

  • matrix metalloproteinase
  • dicarbonyls
  • lung cancer

Schlüsselwörter

  • Matrixmetalloproteinase
  • Dicarbonyle
  • Lunge
  • Krebs